Radcliffe Capital Management’s Estrella Immunopharma, Inc. Warrant ESLAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50,000
| Closed | -$2.62K | – | 476 |
|
|
2023
Q2 | $2.62K | Hold |
50,000
| – | – | ﹤0.01% | 548 |
|
|
2023
Q1 | $4.93K | Hold |
50,000
| – | – | ﹤0.01% | 616 |
|
|
2022
Q4 | $515K | Hold |
50,000
| – | – | 0.02% | 779 |
|
|
2022
Q3 | $503K | Hold |
50,000
| – | – | 0.01% | 1067 |
|
|
2022
Q2 | $500K | Hold |
50,000
| – | – | 0.01% | 1120 |
|
|
2022
Q1 | $500K | Hold |
50,000
| – | – | 0.01% | 1120 |
|
|
2021
Q4 | $496K | Hold |
50,000
| – | – | 0.01% | 970 |
|
|
2021
Q3 | $495K | Buy |
+50,000
| New | +$495K | 0.01% | 826 |
|